Jefferies Group LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$75.71 - $119.24 $2.69 Million - $4.23 Million	35,500 Added 118.33%	65,500 $7.24 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $2.69 Million - $4.23 Million	35,500 Added 118.33%	65,500 $7.24 Million
Q1 2022 Sep 21, 2023	SELL	$63.15 - $90.42 $8.93 Million - $12.8 Million	-141,400 Reduced 82.5%	30,000 $2.34 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $8.93 Million - $12.8 Million	-141,400 Reduced 82.5%	30,000 $2.34 Million
Q4 2021 Sep 21, 2023	BUY	$77.28 - $99.42 $11.5 Million - $14.9 Million	149,400 Added 679.09%	171,400 $15.4 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $13.2 Million - $17 Million	171,400 New	171,400 $15.4 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $1.45 Million - $2.03 Million	-22,000 Closed	0 $0
Q2 2021 Sep 21, 2023	SELL	$69.38 - $86.75 $208,140 - $260,250	-3,000 Reduced 12.0%	22,000 $1.71 Million
Q2 2021 Aug 20, 2021	SELL	$69.38 - $86.75 $151 Million - $189 Million	-2,178,000 Reduced 99.0%	22,000 $1.71 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $151 Million - $189 Million	2,175,000 Added 8700.0%	2,200,000 $1.71 Million
Q1 2021 Sep 21, 2023	SELL	$72.25 - $168.95 $2.93 Million - $6.84 Million	-40,500 Reduced 61.83%	25,000 $1.86 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $1 Million - $2.35 Million	-13,900 Reduced 35.73%	25,000 $1.86 Million
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $24.2 Million - $43 Million	-316,800 Reduced 89.06%	38,900 $5.02 Million
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $14.8 Million - $31.9 Million	203,600 Added 133.86%	355,700 $26.8 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $12.8 Million - $17.3 Million	-113,700 Reduced 42.78%	152,100 $23.1 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $27.2 Million - $38.7 Million	255,400 Added 2455.77%	265,800 $31.7 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $3.9 Million - $5.46 Million	-33,800 Reduced 76.47%	10,400 $1.68 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $3.17 Million - $6.79 Million	44,200 New	44,200 $5.84 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $2.72 Million - $4.15 Million	-50,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $4,764 - $5,675	100 Added 0.2%	50,400 $2.8 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $1.8 Million - $2.37 Million	50,300	50,300 $2.28 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.25 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.09 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$759 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$528 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$518 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.6B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account